Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

105.35
-3.4300-3.15%
Post-market: 104.68-0.6700-0.64%18:07 EDT
Volume:1.17M
Turnover:123.65M
Market Cap:25.26B
PE:-48.66
High:107.46
Open:105.77
Low:103.48
Close:108.78
Loading ...

Positive Outlook for Evonik: Buy Rating Supported by Strong FY-25 Guidance and Cost Savings

TIPRANKS
·
05 Mar

Bayer’s Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

TIPRANKS
·
05 Mar

FDA Places Hold on BioNTech’s Malaria Vaccine Trial

TIPRANKS
·
05 Mar

BioNTech - FDA Placed Clinical Hold On Ind Application & Related Phase I/IIA Clinical Trial (Nct06069544)

Reuters
·
05 Mar

BioNTech reports FDA clinical hold on Phase I/IIa trial of BNT165e

TIPRANKS
·
05 Mar

Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody

Simply Wall St.
·
05 Mar

Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025

NewMediaWire
·
04 Mar

Five Years Since Covid-19: Revisiting Indonesia's Response and Jokowi's Lockdown Rejection

Tempo
·
04 Mar

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

PR Newswire
·
04 Mar

Bertrandt AG Managerial Share Purchase Signals Confidence

TIPRANKS
·
04 Mar

GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy

NewMediaWire
·
03 Mar

Morgan Stanley Reaffirms Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
03 Mar

Is BioNTech SE (BNTX) The Best Immunology Stock To Buy Now?

Insider Monkey
·
02 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week

MT Newswires Live
·
01 Mar

Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations

GlobeNewswire
·
28 Feb

InflaRx to Showcase Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

GlobeNewswire
·
28 Feb